Emily
| Introduction | Emily Walsh is a “recovering scientist”. Prior to Halloran, she held program management roles across a number of therapeutic areas at the Novartis Institutes for BioMedical Research and Alnylam. Most recently Emily spent four months assessing 15,000 disease indications for their preclinical and clinical ease of operational execution. |
|---|